ASAS-PerSpA study finds Japanese patients with axial psoriatic arthritis have lower disease activity and better function than ...
AbbVie to present data from multiple studies of Rinvoq, Humira & Skyrizi at the 2019 ACR/ARP) meeting: North Chicago, Illionis Tuesday, November 5, 2019, 16:00 Hrs [IST] AbbVie, a ...
Pfizer Inc. announced positive results from a phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS). Tofacitinib is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback